| 注册
首页|期刊导航|中国现代中药|中药有效成分作用于肝星状细胞抗肝纤维化分子机制研究进展

中药有效成分作用于肝星状细胞抗肝纤维化分子机制研究进展

常虹 郭凯 孟洪宇 刘树民

中国现代中药2017,Vol.19Issue(1):148-153,6.
中国现代中药2017,Vol.19Issue(1):148-153,6.DOI:10.13313/j.issn.1673-4890.2017.1.029

中药有效成分作用于肝星状细胞抗肝纤维化分子机制研究进展

Advances in Mechanistic Studies on Anti-liver Fibrosis of Active Components of Chinese Medicine by Targeting Hepatic Stellate Cells

常虹 1郭凯 2孟洪宇 3刘树民4

作者信息

  • 1. 黑龙江中医药大学中医药研究院,黑龙江哈尔滨150040
  • 2. 包头医学院药学院,内蒙古包头014060
  • 3. 中国中药公司,北京 100195
  • 4. 北京中医药大学,北京100029
  • 折叠

摘要

Abstract

Hepatic fibrosis is an integral clinicopathological condition of chronic liver disease.Inhibition of HSC activation and clearance of activated HSC become key to the prevention and treatment of hepatic fibrosis.Chinese medicine antiliver fibrosis of active by measures of multi-channel,multi-target and a variety of cytokines and cell pathway in hepatic stellate cells,molecular mechanim of the activation and apoptosis of HSC and the studies on the anti-liver fibrosis of active ingredients were reviewed in this paper,which could provide some references for the further study about the anti-hepatic fibrosis.

关键词

中药有效成分/肝星状细胞/肝纤维化/分子机制

Key words

Active components of Chinese medicine/hepatic stellate cells (HSCs)/hepatic fibrosis/mechanism

引用本文复制引用

常虹,郭凯,孟洪宇,刘树民..中药有效成分作用于肝星状细胞抗肝纤维化分子机制研究进展[J].中国现代中药,2017,19(1):148-153,6.

基金项目

国家重点基础研究项目(973计划)(2013CB531804) (973计划)

中国现代中药

OACSTPCD

1673-4890

访问量0
|
下载量0
段落导航相关论文